# Open Label Ketamine Treatment for Major Depressive Disorder in Veterans

> **NCT03053830** · PHASE2 · COMPLETED · sponsor: **VA Connecticut Healthcare System** · enrollment: 11 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Ketamine

## Key facts

- **NCT ID:** NCT03053830
- **Lead sponsor:** VA Connecticut Healthcare System
- **Sponsor class:** FED
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-31
- **Primary completion:** 2018-09-26
- **Final completion:** 2018-09-26
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03053830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03053830, "Open Label Ketamine Treatment for Major Depressive Disorder in Veterans". Retrieved via AI Analytics 2026-07-11 from https://api.ai-analytics.org/clinical/NCT03053830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*